Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Change in Account Payables (2025 - 2026)

Updated

Aptevo Therapeutics' Change in Account Payables came in at $272,000 for Q2 2026, compared with -$936,000 a year earlier.

Analysis

Aptevo Therapeutics (APVO) Change in Account Payables (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aptevo Therapeutics reported Change in Account Payables of -$373,000.

  • The Q2 2026 figure represents the highest quarterly Change in Account Payables since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn - 272,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 272,000.00
Mar 31, 2026 13,000.00
Jun 30, 2025 -936,000.00
Mar 31, 2025 278,000.00
API Access

Aptevo Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=APVO&period=max&api_key=YOUR_API_KEY